NASDAQ:ACB Aurora Cannabis Q2 2027 Earnings Date & Estimates $4.43 +0.01 (+0.11%) As of 01:42 PM Eastern This is a fair market value price provided by Massive. Learn more. Aurora Cannabis is scheduled to report Q2 2027 earnings on Wednesday, November 4, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ2 2027Announcement DateNovember 4, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Aurora Cannabis in Q2 2027Aurora Cannabis is expected to post earnings of -$0.03 per share on revenue of $50.68 million. In the same quarter a year earlier Aurora Cannabis reported $0.09 per share on revenue of $64.88 million. Aurora Cannabis last reported on August 5, 2026, posting $0.04 per share and beating the -$0.13 consensus estimate. Aurora Cannabis has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.03Expected Revenue$50.68 millionPrior-Year EPS$0.09Prior-Year Revenue$64.88 millionExpected EPS Growth-133.3%Expected Revenue Growth-21.9%Recent Track RecordLast ReportedQ1 2027Last Quarter EPS$0.04 (Beat by +$0.17)Last Quarter Revenue$47.62 millionEPS Beat Rate5 of last 8 quartersPrepare for the Q2 2027 CallEarnings HistoryCompany ProfileQ1 2027 Earnings ReportQ4 2026 Earnings ReportQ3 2026 Earnings Report Aurora Cannabis Q2 2027 Earnings FAQ When does Aurora Cannabis report Q2 2027 earnings? Aurora Cannabis (NASDAQ:ACB) is scheduled to report Q2 2027 earnings on Wednesday, November 4, 2026, before market opens. What time is Aurora Cannabis' Q2 2027 earnings call? Aurora Cannabis' Q2 2027 earnings conference call is scheduled for Wednesday, November 4, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Aurora Cannabis? Analysts expect Aurora Cannabis to post earnings of -$0.03 per share for Q2 2027. How much revenue is Aurora Cannabis expected to report? The consensus revenue estimate for Aurora Cannabis is $50.68 million for Q2 2027. Aurora Cannabis Earnings HeadlinesAurora Cannabis Completes Expansion of German FacilityOctober 8 at 6:06 PM | finance.yahoo.comTilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis EaseOctober 8 at 10:09 AM | 247wallst.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 9 at 1:00 AM | Stansberry Research (Ad)Curaleaf Holdings (TSX:CURA) Could Be 24% Undervalued After Its Raised Aurora BidOctober 8 at 7:55 AM | finance.yahoo.comAurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower OutputOctober 8 at 7:55 AM | finance.yahoo.comAurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower OutputOctober 8 at 7:05 AM | prnewswire.comSee More Aurora Cannabis Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email. Email Address About Aurora CannabisAurora Cannabis (NASDAQ:ACB) is a Canadian cannabis company focused primarily on the production, distribution and sale of medical cannabis. The company offers cannabis products such as dried flower, pre-rolls, oils, softgels, capsules and other formulations through its medical and consumer brands. Founded in 2013 and headquartered in Edmonton, Alberta, Aurora serves adult-use and medical markets in Canada and supplies medical cannabis to selected international markets. Its international operations and partnerships have included markets in Europe, Australia and other regions where cannabis is permitted for medical use. Aurora sells products under brands including Aurora, CanniMed, MedReleaf and San Rafael '71. The company is led by Chief Executive Officer Miguel Martin and is listed on the Nasdaq Capital Market under the symbol ACB.View Aurora Cannabis ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
